Basma Adeem Medical Co. (Smile Care) reported a net profit of SAR 6.3 million for 2024, an increase of 29% from SAR 4.9 million a year earlier.
Item | 2023 | 2024 | Change |
---|---|---|---|
Revenues | 26.52 | 33.92 | 27.9 % |
Gross Income | 8.35 | 11.01 | 32.0 % |
Operating Income | 5.25 | 6.97 | 32.7 % |
Net Income | 4.87 | 6.30 | 29.4 % |
Average Shares | 8.26 | 16.00 | 93.8 % |
Earnings Per Share before unusual items (Riyals) | 0.59 | 0.39 | (33.2 %) |
EPS (Riyal) | 0.59 | 0.39 | (33.2 %) |
The profit increase was driven by an increase in revenue by 27.88% to SAR 33.91 million compared to SAR 26.52 million in the previous year, due to higher capacity and higher number of doctors and patients.
Meanwhile the company’s gross profit grew 31.97%.
Item | H2 2023 | H2 2024 | Change |
---|---|---|---|
Revenues | 14.79 | 18.51 | 25.1 % |
Gross Income | 4.86 | 6.40 | 31.6 % |
Operating Income | 3.01 | 4.33 | 43.8 % |
Net Income | 2.89 | 3.92 | 35.4 % |
Average Shares | 8.26 | 16.00 | 93.8 % |
Earnings Per Share before unusual items (Riyal) | 0.35 | 0.24 | (30.1 %) |
EPS (Riyal) | 0.35 | 0.24 | (30.1 %) |
Item | H1 2024 | H2 2024 | Change |
---|---|---|---|
Revenues | 15.41 | 18.51 | 20.1 % |
Gross Income | 4.61 | 6.40 | 38.8 % |
Operating Income | 2.64 | 4.33 | 64.0 % |
Net Income | 2.38 | 3.92 | 64.4 % |
Average Shares | 16.00 | 16.00 | - |
Earnings Per Share before unusual items (Riyal) | 0.15 | 0.24 | 64.4 % |
EPS (Riyal) | 0.15 | 0.24 | 64.4 % |
In H2 2024, net profit rose 35.4% to SAR 3.92 million from SAR 2.89 million a year earlier.
Sequentially, H2 2024 profit grew 64.4% from SAR 2.38 million in H1 2024.
Total shareholders’ equity, no minority interest, stood at SAR 22.3 million as of Dec. 31, 2024, up from SAR 9.8 million in the prior-year period.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: